stockrow
Friday 6 November 2026
Export VKTX’s income statement to Excel — free account
Viking Therapeutics, Inc.
VKTX Healthcare Biotechnology
- EPS
- −91.6%
- Free cash flow
- −47.0%
Quarter to September 2026, against a year earlier
26.84
1.05
+4.07%
Follow VKTX
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
9.33 | 33.09 | 19.19 | 7.61 | 23.98 | 21.12 | 41.83 | 66.40 | 2.52 | 2.16 |
Net Debt/EBITDA |
1.76 | 5.38 | 3.33 | 2.26 | 3.93 | 6.46 | 8.71 | 12.11 | 1.06 | 0.84 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15.60% | 22.49% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.41 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.77 | 0.80 | 0.85 | 0.70 | 0.87 | 0.55 | 0.96 | 0.85 | 0.72 | 0.75 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
— | — | — | (44.28) | (79.21) | (13.20) | (4.64) | (7.99) | 19,070.00 | (632.30) |
| (47.34%) | (17.90%) | (34.79%) | (39.67%) | (24.65%) | (15.15%) | (8.97%) | (14.18%) | (191.36%) | (175.71%) | |
| (44.29%) | (17.22%) | (31.99%) | (36.32%) | (23.54%) | (14.61%) | (8.79%) | (13.60%) | (112.27%) | (98.29%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,379.43%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(56.29%) | (12.50%) | (24.68%) | (47.46%) | (27.26%) | (16.19%) | (9.32%) | (7.41%) | (155.96%) | (196.47%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.47) | (0.81) | (0.78) | (0.63) | (0.62) | (0.30) | (0.34) | (0.33) | (0.57) | (0.68) |
Cash per Share |
6.26 | 8.28 | 3.84 | 2.02 | 2.62 | 3.42 | 3.83 | 5.24 | 0.79 | 0.81 |
Shareholders Equity per Share |
5.67 | 8.07 | 3.69 | 1.89 | 2.62 | 3.37 | 3.85 | 5.17 | 0.52 | 0.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.67 | 8.07 | 3.69 | 1.89 | 2.62 | 3.37 | 3.85 | 5.17 | 0.52 | 0.49 |
Free Cash Flow |
(278.68) | (87.79) | (73.38) | (48.40) | (47.59) | (21.78) | (24.75) | (18.75) | (14.76) | (11.07) |
Working Capital |
638.93 | 879.80 | 348.09 | 145.09 | 201.75 | 243.98 | 276.72 | 297.58 | 13.19 | 7.50 |
Net Current Asset Value |
638.93 | 879.17 | 347.15 | 143.83 | 201.75 | 243.95 | 276.36 | 297.57 | 13.19 | 7.48 |
| Other line items | ||||||||||
Quick Ratio |
9.21 | 32.93 | 18.92 | 7.08 | 23.02 | 20.48 | 40.67 | 66.27 | 2.38 | 2.03 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(20.72%) | (4.92%) | (10.33%) | (16.09%) | (11.78%) | (4.42%) | (4.48%) | (3.13%) | (39.37%) | (45.26%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.47) | (0.81) | (0.78) | (0.63) | (0.62) | (0.30) | (0.34) | (0.33) | (0.57) | (0.68) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
31.53 | 8.66 | 8.02 | 4.99 | 2.72 | 3.21 | 1.70 | 1.24 | 1.37 | 0.90 |
Average Assets |
812.03 | 638.41 | 268.51 | 189.60 | 233.58 | 270.38 | 293.28 | 162.22 | 18.33 | 14.99 |
Average Common Equity |
759.67 | 614.35 | 246.87 | 173.60 | 223.11 | 260.73 | 287.43 | 155.61 | 10.75 | 8.38 |
Columns are period end dates · fundamentals updated 2 Nov 2026